E-viri
PDF
Recenzirano
Odprti dostop
-
Thomas, Anish, MD; Chen, Yuanbin, MD, PhD; Berman, Arlene, MS; Schrump, David S., MD; Giaccone, Giuseppe, MD, PhD; Pastan, Ira, MD; Venzon, David J., PhD; Liewehr, David J., MS; Steinberg, Seth M., PhD; Miettinen, Markku, MD; Hassan, Raffit, MD; Rajan, Arun, MD
Lung cancer (Amsterdam, Netherlands), 11/2016, Letnik: 101Journal Article
Highlights • Mesothelin, a cell surface antigen is a target for tumor-directed therapy. • Thymic carcinomas frequently demonstrate strong mesothelin expression. • High mesothelin expression in thymic carcinoma is associated with longer survival. • Mesothelin-directed therapy should be evaluated in advanced thymic carcinoma.
